AcelRx Pharmaceuticals: How The Licensing Agreements Could Become A Shot In The Arm
Klaus Vedfelt/DigitalVision via Getty Images
I have covered AcelRx Pharmaceuticals (NASDAQ:ACRX) before, so investors should view this as an update to my previous articles.
On July 14, 2021, ACRX announced that it had entered into a Licensing Agreement…
